Not dependent on 2 vaccines only, India developing 7 more Covid-19 vaccines: Dr Harsh Vardhan

Three of the Covid-19 vaccines are in the trial phase, two are in the pre-clinical stage, one is in phase 1 and another in phase 2, the Union Health Minister, Dr Harsh Vardhan said.

Published On 2021-02-08 03:45 GMT   |   Update On 2021-02-08 03:45 GMT

Kolkata: Union Health Minister Harsh Vardhan on Saturday said that the country is developing seven more COVID-19 vaccines and also working on further vaccine development to inoculate every citizen of India.

He said the Centre does not have any immediate plan to make the vaccines available in the open market and a decision will be taken as the situation demands.

Also Read: India received request for supply of Covid-19 vaccines from 22 countries: Harsh Vardhan

The COVID-9 inoculation process for people aged above 50 will start in March, he told reporters.

"We are not dependent only on the two vaccines as the country is working on seven more indigenous vaccines. Simultaneously, we are also working on the development of more vaccines because India is a huge country and we need more players and research to reach out to everyone," he said.

Three of the vaccines are in the trial phase, two are in the pre-clinical stage, one is in phase 1 and another in phase 2, the Union health minister said.

"The COVID-19 inoculation process for people above 50 years of age will start next month," he said.

"Presently, COVID-19 vaccines are being administered on an emergency basis, under full observation and in a controlled manner. If the vaccines are released in the open market, there won't be any control over them. The decision will be taken as the situation demands," he added.

Two COVID vaccines Covishield and Covaxin are being administered to healthcare and the frontline workers during the ongoing initial stages of the inoculation process.

Covishield, AstraZeneca's COVID-19 vaccine, has been developed by the University of Oxford.

Covaxin is India's first indigenous COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV).

Also Read:PGIMER Director, wife take Covid-19 vaccine jab

Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News